ADMA Biologics Inc (ADMA) vs Vericel Corporation (VCEL)
ADMA Biologics Inc and Vericel Corporation are both Biotechnology companies. ADMA Biologics Inc and Vericel Corporation are of similar size ($2.1B and $2.0B). ADMA Biologics Inc trades at the lower P/E: 13.0× against 82.6×. Vericel Corporation grew revenue faster over the last twelve months: 23.0% against 8.04%. ADMA Biologics Inc has the higher net margin (33.0% vs 7.91%) and the higher return on invested capital (29.8% vs 5.49%). Across the 22 metrics below, ADMA Biologics Inc leads on 16 and Vericel Corporation on 6.
Valuation
Profitability
| Metric | ADMA | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.71% | 74.56% | 65.16% |
| Operating margin | 43.82% | 5.95% | 0.00% |
| Net margin | 32.98% | 7.91% | 0.00% |
| Free cash flow margin | 22.69% | 20.13% | 0.00% |
| Return on equity | 41.90% | 7.16% | (57.72%) |
| Return on assets | 27.19% | 5.16% | (49.22%) |
| Return on invested capital | 29.78% | 5.49% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack